Skip to content

Study · Not a test of the peptide alone · 1994

2 results

Theoretical and experimental epitope mapping of thymosin beta 4.

Becker S, Armbruster FP, Müller B, Echner H, Kapurnotu A, Livaniou E, Mihelić M, Stoeva S, Voelter W

Journal of immunological methods1 Dec 1994Cited by 4 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    A rabbit polyclonal serum against thymosin beta‑4 detected three epitopes: N-terminal, mid-region and C-terminal.

    In plain wordsIn lab tests, an antiserum made against thymosin beta‑4 recognised three parts of the peptide.

    Outcome
    Not applicableEpitopes detected by anti-thymosin beta 4 serum
    Study

    n: not reported in source

    Overlapping hexapeptides on polystyrene pins, ELISA
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The polyclonal serum against thymosin beta 4 detected three epitopes (N-terminal, mid-region and C-terminal)
    1 context sentence
    Summary · context
    Two rabbit polyclonal antisera, one directed against thymosin beta 4 and the other one against the peptide fragment thymosin beta 4 (1-14) were characterised by epitope mapping. Hexapeptides representing the whole sequence of the native peptide and overlapping by one amino acid were synthesised on polystyrene pins.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

  2. 02LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    A rabbit polyclonal serum against thymosin beta‑4 (1-14) contained only antibodies specific for the N-terminal epitope.

    In plain wordsIn lab tests, an antiserum made against the first 14 amino acids of thymosin beta‑4 recognised only the N-terminal part.

    Outcome
    Not applicableEpitopes detected by anti-fragment serum
    Study

    n: not reported in source

    Overlapping hexapeptides on polystyrene pins, ELISA
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    the polyclonal serum against the fragment contained only antibodies specific for the N-terminal epitope.
    1 context sentence
    Summary · context
    Two rabbit polyclonal antisera, one directed against thymosin beta 4 and the other one against the peptide fragment thymosin beta 4 (1-14) were characterised by epitope mapping. Hexapeptides representing the whole sequence of the native peptide and overlapping by one amino acid were synthesised on polystyrene pins.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.